Trade Sinopharm Group Co. Ltd. - 1099 CFD

Trading Conditions

• TypeThis financial market is available for CFD trading.Learn more about:CFDs: CFD
• Spread: 0.1
• Long position overnight funding adjustmentLong position overnight funding adjustmentMargin. Your investmentHK$1,000.00Overnight funding adjustmentCharges from full value of position-0.01846 %(-HK$3.69)Trade size with leverage ~ HK$20,000.00Money from leverage ~ $HK$19,000.00Go to platform: -0.01846%
• Short position overnight funding adjustmentShort position overnight funding adjustmentMargin. Your investmentHK$1,000.00Overnight funding adjustmentCharges from full value of position-0.00346 %(-HK$0.69)Trade size with leverage ~ HK$20,000.00Money from leverage ~ $HK$19,000.00Go to platform: -0.00346%
• Overnight funding adjustment time: 21:00 (UTC)
• Currency: HKD
• Min traded quantity: 10
• Margin: 5.00%
• Stock exchange: Hong Kong
• Commission on trade: 0%
• Guaranteed stop premiumA guaranteed stop-loss (GSL) fee is only charged if the GSL is triggered. Please consult the Charges and Fees section of our website for more details.: 1%

• Margin. Your investment: HK$1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.01846 %
  (-HK$3.69)

• Margin. Your investment: HK$1,000.00
• Overnight funding adjustmentCharges from full value of position: -0.00346 %
  (-HK$0.69)

Key Stats

• Prev. Close: 15.55
• Open: 15.85
• 1-Year Change: -14.32%
• Day's Range: 15.6 - 15.9

Trade Sinopharm Group Co. Ltd. - 1099

About SINOPHARM HOLDING CO LTD

Sinopharm Group Co Ltd is a China-based company principally engaged in pharmaceutical and medical devices distribution business. The Company operates its business through four segments. Pharmaceutical Distribution segment is engaged in the distribution of pharmaceutical products to hospitals, other distributors, retail pharmacy stores and clinics. Medical Devices segment is engaged in the distribution of medical devices, as well as provides installation and maintenance services. Retail Pharmacy segment is engaged in the operation of chain pharmacy stores. Other Business segment is engaged in the distribution of laboratory supplies, manufacture and distribution of chemical reagents, production and sale of pharmaceutical products.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, SINOPHARM HOLDING CO LTD revenues increased 14% to RMB521.05B. Net income applicable to common stockholders increased 8% to RMB7.76B. Revenues reflect Retail Sales - Total increase of 20% to RMB28.57B. Net income was partially offset by Impairment of Intangibles increase from RMB265M to RMB606.9M (expense), Bank and other borrowings increase of 10% to RMB2.87B (expense).